This finding suggests a targeted molecular mechanism whereby vitamin C could be utilized in regenerative medicine specifically tailored for periodontal disease treatment, leveraging the PELP1-ERK axis for bone and tissue regeneration. The gene discussed is PELP1; the disease is periodontal disorder.